A change in treatment regimen is required because of very active epileptiform activity during sleep and neuropsychological regression This means that only patients with very active epileptiform activity and therefore with a need for a change in treatment regimen as clinically indicated will be potentially eligible Additionally a prior clinical decision to use clobazam should have been made by the primary epileptologist in order to participate in the study 